Paper1981663
The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents.
Peters W and 4 others. Ann Trop Med Parasitol, 1990. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents. Papers, record 1981663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1981663
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chloroquine | Major topic |
| Histamine Antagonists | Major topic |
| Plasmodium berghei | Major topic |
| Plasmodium yoelii | Major topic |
| Animals | |
| Cyproheptadine | |
| Dose-Response Relationship, Drug | |
| Drug Resistance | |
| Histamine H1 Antagonists | |
| Humans | |
| In Vitro Techniques | |
| Ketotifen | |
| Loratadine | |
| Pizotyline | |
| Rats |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32731386 | Repurposing Drugs to Fight Hepatic Malaria Parasites. | Molecules | 2020 | https://conductscience.org/library/papers/32731386 | PubMed |
| 29061761 | Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29061761 | PubMed |
| 28279945 | Quantitative characterization of hemozoin in Plasmodium berghei and vivax. | Int J Parasitol Drugs Drug Resist | 2017 | https://conductscience.org/library/papers/28279945 | PubMed |
| 27048943 | Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents. | Bioorg Med Chem Lett | 2016 | https://conductscience.org/library/papers/27048943 | PubMed |
| 25616344 | Arteether resistance reversal by ketoconazole/fluconazole in rodent malaria parasite Plasmodium vinckei. | Parasitol Res | 2015 | https://conductscience.org/library/papers/25616344 | PubMed |
| 23547773 | Effective treatment with a tetrandrine/chloroquine combination for chloroquine-resistant falciparum malaria in Aotus monkeys. | Malar J | 2013 | https://conductscience.org/library/papers/23547773 | PubMed |
| 20807203 | Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross. | Mol Microbiol | 2010 | https://conductscience.org/library/papers/20807203 | PubMed |
| 17846138 | Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17846138 | PubMed |
| 16377670 | In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16377670 | PubMed |
| 15215144 | Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15215144 | PubMed |
| 12069956 | In vitro increase in chloroquine accumulation induced by dihydroethano- and ethenoanthracene derivatives in Plasmodium falciparum-parasitized erythrocytes. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12069956 | PubMed |
| 10991848 | Potent enhancement of the sensitivity of Plasmodium falciparum to chloroquine by the bisbenzylisoquinoline alkaloid cepharanthin. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10991848 | PubMed |
| 10991845 | Role of the neurotransmitter reuptake-blocking activity of antidepressants in reversing chloroquine resistance in vitro in Plasmodium falciparum. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10991845 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1981663
GET https://conductscience.org/api/papers/v1/1981663/authors